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Background: Depersonalization (DP) and derealization (DR) are symptoms of a disruption
of perceptual integration leading to an altered quality of subjective experiences such as
feelings of unreality and detachment from the self (DP) or the surroundings (DR). Both DP
and DR often occur in concert with other symptoms, for example in subjects at clinical
high-risk (CHR) for psychosis, but also appear isolated in the form of DP/DR disorder.
Despite evidence that DP/DR causes immense distress, little is known about their
neurobiological underpinnings. Therefore, we investigated the neural correlates of DP/
DR using pseudo-continuous arterial spin labeling MRI.
Methods:We evaluated the frequency of DP/DR symptoms in a clinical sample (N = 217)
of help-seeking individuals from the Early Detection and Intervention Centre for Mental
Crisis (CHR, n = 97; clinical controls (CC), n = 91; and first-episode psychosis (FEP), n =
29). Further, in a subsample of those CHR subjects who underwent MRI, we investigated
the resting-state regional cerebral blood flow (rCBF). Here, individuals with (n = 21) and
without (n = 23) DP/DR were contrasted. Finally, rCBF was measured in a small
independent second sample of patients with DP/DR disorder (n = 6) and healthy
controls (HC, n = 6).
Results: In the complete clinical sample, significantly higher frequency of DP/DR was
found in CHR compared to CC (50.5 vs. 16.5%; c2(2) = 24.218, p ≤ 0.001, Cramer’s V =
0.359) as well as in FEP compared to CC (37.9 vs. 16.5%; c2(2) = 5.960, p = 0.015,g September 2020 | Volume 11 | Article 5356521
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Frontiers in Psychiatry | www.frontiersin.orCramer’s V = 0.223). In MRI, significantly lower rCBF was detected in the left orbitofrontal
cortex in CHR with vs. without DP/DR (x/y/z = −16/42/−22, p < 0.05, FWE corrected). In
patients with DP/DR disorder, significantly higher rCBF was detected in the left caudate
nucleus (x/y/z = −18/−32/18, p < 0.05) compared to HC.
Conclusions: This study shows that DP/DR symptoms are frequently found in CHR
subjects. Investigating two separate DP/DR populations with an identical neuroimaging
technique, our study also indicates that there may be divergent pathophysiological
mechanisms—decreased neuronal activity in the orbitofrontal cortex, but increased activity
within the caudate nucleus—leading to a final common pathway with similar
psychopathological symptoms. This suggests that both top-down (orbitofrontal cortex)
and bottom-up (caudate nucleus) mechanisms could contribute to the emergence of DP/DR.Keywords: clinical high risk for psychosis, depersonalization, derealization, arterial spin labeling, magnetic
resonance imaging, orbitofrontal cortex, caudate nucleusINTRODUCTION
Altered subjective experiences such as feelings of unreality and
detachment from the self or the surroundings are defined as
depersonalization (DP) and derealization (DR). Individuals may
feel detached from the whole self or from aspects of the self,
including feelings, thoughts, body parts or sensations, and from
individuals, objects, or all surroundings, often described as being in
a fog, dream or bubble, being numb, or as if they are under a glass
bell (1–4). DP/DR is a ‘physiological’ perceptual reaction and
psychological phenomenon, especially occurring when stressed,
but also when traumatized, very tired, anxious, or intoxicated,
however, with sustained insight into the subjective nature of the
symptoms. In most cases, these DP/DR experiences are transient,
but in some cases, DP/DR may take a chronic course, persisting for
days, weeks, or months, with episodic or permanent symptoms.
Individuals with DP/DR frequently worry about their mental state
and are frightened of becoming crazy or losing their mind (1, 5).
DP/DR disorder is characterized by a persistent or recurrent
experience of unreality and detachment from oneself or the
surrounding, while reality testing remains intact. It is a primary
mental health disorder and occurs in the absence or only secondary
development of other mental disorders. Symptoms result in
significant distress or impairment in functioning (5, 6).
Common age of onset is adolescence, with earlier onset
associated with higher severity and poorer prognosis (3, 7). In
a systematic review, a prevalence rate of 1.2–2.4% was found for
clinically significant DP/DR symptoms in the community and
30–82% in clinical samples (1). DP/DR disorder is often seen in
clinical conditions as comorbidity, especially in psychoses (1, 8,
9), depression and anxiety disorders (7), and also after cannabis
abuse (10).
Depending on the setting, a review reported DP/DR symptom
rates from 7% in outpatients to 36% in inpatients with manifest
psychosis (1). Patients with manifest psychosis had higher DP/
DR scores according to the ‘Cambridge Depersonalization Scale’
(CDS) (11) compared to first-degree relatives and healthy
controls (12). Furthermore, patients with manifest psychosisg 2were assessed for DP with the ‘Bonn Scale for the Assessment
of Basic Symptoms’ (13) and could be differentiated from those
without DP with the paradigm of Basic Symptoms (14). Basic
symptoms are subtle, subclinical, self-experienced disturbances
in drive, stress tolerance, affect, thinking, speech, perception and
motor action. They are experienced with full insight into their
abnormal nature. Basic symptoms can be present before, during,
and after psychotic episodes (15). Additionally, DP/DR was
found to be more frequent, had a longer duration and was
stronger in the early, compared to the chronic stages, of psychosis
(8). Furthermore, DP/DR symptoms were also reported to occur in
ultra-high risk (UHR) subjects for psychosis (16, 17).
The majority offirst-episode psychotic disorders are preceded by
a prodromal phase in which a multitude of CHR symptoms
(including DP/DR), other mental health problems, and
psychosocial deficits occur, and during which help may be sought
(18–20). This phase offers an excellent starting point for an
indicated prevention that aims at reducing CHR symptoms and,
thereby, preventing transition to frank psychosis (19). Currently,
two major sets of CHR criteria are used to detect a putatively
psychosis-prodromal phase: (i) symptomatic ultra-high risk (UHR)
criteria, i.e., attenuated (APS) or brief intermittent psychotic
symptoms (BIPS); and (ii) basic symptom criteria, i.e., Cognitive
Disturbances (COGDIS) and Cognitive-Perceptive Basic Symptoms
(COPER) (18, 20).
As DP/DR experiences can occur on a continuum from transient
symptoms to chronic ones (1), the question arises whether the
symptoms are caused by similar or distinct pathophysiological
mechanisms in different clinical groups/diagnoses. Previous
studies suggest that different systems such as the fronto-limbic
and the temporo-parietal network are responsible for different DP/
DR symptoms (21). The theory of the fronto-limbic system
proposes that the frontal cortex activity is increased while the
limbic system is inhibited (e.g. amygdala) causing a reduction of
emotional responses (e.g. numbing, perceptual detachment) (22),
whereas the temporo-parietal system could lead to the emergence of
feelings of disembodiment and lack of agency seen in DP/DR
patients (21). Different studies confirmed the involvement of bothSeptember 2020 | Volume 11 | Article 535652
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whole brain magnetic resonance imaging (MRI), fractional
anisotropy, and positron emission tomography (23–26).
Further, symptom improvement of DP/DR showed altered
insula, visual cortex, and cerebellum activation (27). Treatment
of DP/DR with repetitive transcranial magnetic stimulation in
patients with DP/DR disorder showed that inhibition applied to
the ventrolateral prefrontal cortex and temporo-parietal junction
leads to symptom reductions in DP/DR, indicating that both
systems have associations with DP/DR (28, 29). Besides the
fronto-limbic and the temporo-parietal system, the striatum
was also linked to DP/DR (30). These findings, together with
the findings of decreased gray matter in the right caudate, right
thalamus, and right cuneus as well as of gray matter increases in
the left dorsomedial prefrontal cortex and right somatosensory
region (23), and alterations in white matter in the left caudate
nucleus, the right amygdala and brainstem (24) point towards
dysfunctions in different systems.
Taken together, DP/DR symptoms might be linked to brain
regions involving the frontal-limbic and temporo-parietal network
as well as the striatum (2, 4, 21, 30, 31). For a better understanding
of the neuronal mechanisms underlying DP/DR, we used resting
state cerebral blood flow (rCBF), a proxy for localized neuronal
activity that can be measured with arterial spin labeling (ASL)-
MRI (32–34). ASL-MRI measures perfusion using magnetically
labeled arterial blood as a tracer. Thereby, ASL-MRI provides a
quantifiable measure of regional cerebral blood flow (in ml/min/
100 g brain tissue) reflecting the level of glucose metabolism which
is associated with neuronal activity of the respective cerebral area
(34, 35). We have previously used ASL to successfully capture
specific psychopathological symptoms (36–40).
Our aim was to evaluate the frequency of DP/DR symptoms
in CHR subjects in a first step and—in a second step—to
investigate the neuronal correlates of DP/DR symptoms using
the same neuroimaging method in two different clinical samples.
First, we assessed the frequency of DP/DR in help-seeking
subjects at an early detection service. Second, we assessed rCBF
with ASL-MRI in CHR subjects with and without DP/DR
symptoms (sample 1). Third, we compared rCBF of a small
sample fulfilling criteria for DP/DR disorder with healthy
controls (sample 2). We expected to find a high frequency of
DP/DR symptoms in CHR and, associated with DP/DR, rCBF
alterations in frontal, temporal, or striatal areas in both samples.MATERIALS AND METHODS
Sample and Assessments
Two independent samples were assessed for this study. The first
sample (sample 1) was recruited at the Bern Early Recognition
and Intervention Center for Mental Crisis (FETZ Bern; www.
upd.ch/de/angebot/erwachsenenpsychiatrie/ambulant-fetz.php)
between November 2009 and June 2018. Individuals with various
psychiatric symptoms were admitted to the FETZ Bern by
physicians, psychosocial institutions, or of their own initiative,
whenever there was clinical suspicion for a developing psychoticFrontiers in Psychiatry | www.frontiersin.org 3disorder. The second sample (sample 2) was recruited at the
University Hospital of Psychiatry and Psychotherapy in Bern
between July 2011 and January 2013 and consisted of patients
with DP/DR disorder, exclusively, as well as of healthy controls.
All procedures contributing to this work comply with the
ethical standards of the relevant national and institutional
committees on human experimentation and with the Helsinki
Declaration of 1975, as revised in 2013. The human research
ethics committee of the Canton Bern approved the study (ID
PB_2016-01991, KEK-095/10). All participants gave informed
consent, and in minors, parental informed consent was provided.
Psychopathology Assessment of Sample 1
Data from 245 subjects who were examined in the FETZ Bern
entered the analyses. The FETZ Bern is the only early detection and
intervention center for psychosis in the Canton of Bern,
Switzerland, with a catchment area of approximately 1.5 million
inhabitants, screening ~80 patients/year (aged 8–40 years) according
to the European Psychiatric Association (EPA) guidelines (19, 20).
The basic assessment includes a psychopathological evaluation, a
cognitive test battery, MRI, and blood screening. Individuals were
diagnosed as clinical controls (CC), first episode psychosis (FEP), or
CHR (41). CHR and related symptoms were assessed by trained
psychologists using semi-structured interviews including the
‘Schizophrenia Proneness Instruments Child & Youth and Adult’
(SPI-CY and SPI-A) to evaluate basic symptoms (42, 43), the
‘Structured Interview for Prodromal Syndromes’ (SIPS) (44), and
the rating from the Comprehensive Assessment of At-Risk Mental
States (CAARMS earlier version than 2006) (45) to evaluate UHR
and related symptoms.
The SPI-A and later the SPI-CY were developed based on the
BSABS. They assess the same concepts and are semi-structured
interviews. However, the SPI-CY/SPI-A assesses the symptoms
on a quantitative 7-point rating scale, as opposed for the BSABS
which rates the symptoms qualitatively for their presence or
absence only (13, 46). For more information about the various
assessments, we refer to the EPA guidelines (20).
DP/DR symptoms can be assessed either with the SIPS and/or
the SPI-CY/SPI-A. The SIPS rates DP/DR items (P1 and N4) in a
lifetime; however, we focused on symptoms measured via SPIA/
SPICY as we aimed to capture present symptoms (symptoms that
were present within the last three months). Therefore, DP/DR was
assessed within the last three months using operationalized items
from the SPI-CY/SPI-A. Derealization (SPI-CY: item B7; SPI-A:
item O8) was assessed from age 13 onwards (requires self-reflection
and higher metacognitive processes) and is defined as a change in
how the person relates emotionally to the world, i.e. by an ‘as if’-
feeling that the world is not real or of oneself being estranged from it
while knowing at the same time that it is real, and they are a part of
it (see Supplementary Text S1 for a detailed description).
Depersonalization is rated in the SPI-CY from age 13 onwards
with the items somatopsychic depersonalization (B8.2), i.e., feeling
estranged from one’s own body and autopsychic depersonalization
(C6), i.e., feeling estranged from one’s own actions, feelings or
emotions, in any case, while being fully aware that it is them. In the
SPI-A, only somatopsychic depersonalization (F6) can be assessed
(see Supplementary Text S1).September 2020 | Volume 11 | Article 535652
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to the maximum frequency of their occurrence within the past
three months ranging from ‘0’ (absent = symptom has not
occurred in the past 3 months) to ‘6’ (extreme = symptom has
occurred daily over sometime within the past 3 months).
Symptoms may also be rated as ‘7’ (symptom has always been
present in same severity; trait), ‘8’ (symptom is definitively
present, but its frequency of occurrence is unknown), and ‘9’
(the presence of the symptom can neither be unambiguously
ruled in nor out). To dichotomize subjects into either having DP/
DR symptoms or not, subjects scoring in any of the items from 1
to 6 or 8 were rated as having DP/DR, while subjects with no
symptoms (0), unclear symptoms (9), or symptoms as traits (7)
were considered to have no DP/DR.
Due to five abortions of the clinical assessments, 13 persons
being younger than 13 years and 10 missing values for DP/DR
due to incomplete interviews, complete behavioral data was
accessible from 217 subjects. The CC did not fulfill any CHR
criterion nor did they have a history of past or present psychosis,
but they were help-seeking individuals fulfilling other psychiatric
diagnoses (see Table 1). FEP fulfilled a past or present psychosis
and CHR subjects did not fulfill a past or present psychosis but
the CHR criterion.
Additionally, the Mini-International Neuropsychiatric Interview
for adults (MINI) (47) and its version for children (MINI-Kid) (48)
were used to assess diagnoses. Psychosocial functioning was
evaluated with the ‘Social and Occupational Functioning
Assessment Scale’ (SOFAS) (49).
MRI Sample 1 of CHR Subjects
We further selected all CHR subjects of sample 1 with available ASL-
MRI scans and after artifact rejection (n = 2). In total, of 44 (45.3%)
participants (MRI scans were notmandatory) out of 97CHR subjects,
ASL data was available. These 44 CHR subjects were analyzed to
investigate differences in rCBF comparing CHR subjects with (n = 21,
21.6%) and without (n = 23, 23.7%) DP/DR symptoms.MRI Sample 2 of DP/DR Disorder Patients
and Healthy Controls
From six patients (not being part of the other study) with DP/DR
disorder according to ICD-10 (five males) aged between 16 and 34
(24.3 ± 7.9 years) and six healthy subjects (three males; 27.0 ± 1.8
years) ASL-MRI scans were analyzed. To assess DP/DR in patients,
the CDS (11) was used in the German version, which was found to
be reliable (a = .95) (50). This self-rating questionnaire consists of
29 items assessing characteristics of depersonalization and
derealization (11). Five factors could be extracted from the CDS
numbing of emotions, altered body perception, feeling unreal,
distorted sense of time, and an unreal seeming environment (51).
For each DP/DR experience, the duration and frequency during the
last six months were assessed by means of a Likert scale. All patients
fulfilled the clinical diagnosis of DP/DR disorder according to ICD-
10 (F48.1) assessed through trained interviewers and had CDS
scores of 70 ± 39 (Mdn = 63), indicating mean to high levels of DP/
DR symptoms. A convenience sample of six healthy controls didFrontiers in Psychiatry | www.frontiersin.org 4not met the criteria for any ICD-10 diagnosis. As none of this
sample had been suspected to develop psychosis and, therefore,
referred to the FETZ Bern, this sample was not examined for
CHR criteria.
MRI Data Acquisition and Processing
The 3.0-Tesla whole-body Siemens MRI system (Magnetom Verio,
Siemens Medical Systems, Erlangen, Germany) produced high-
resolution structural MRI scans and ASL data in one single
session while the subjects were laying alert but with their eyes
closed in the MRI. In addition, T1-weighted 3D modified driven
equilibrium Fourier transform (MDEFT) images were generated as
templates (number of slices, 176; matrix, 256 × 256; slice thickness,
1 mm; voxel size, 1 × 1 × 1mm3) to enable subsequent co-recording
of functional data (52). For the pseudo-continuous ASL, interleaved
images with and without labeling were obtained in gradient-echo
echo-planar imaging sequence (field of view, 220 mm2; matrix, 64 ×
64; flip angle, 25°; tagging duration, 1,600 ms; post-labeling delay,
1,250ms; TR/TE, 4,000ms/13ms; 100 volumes) (32, 33). The entire
brain was contained by the fourteen axonal slices (6 mm thickness
and 1.5 mm gap), which were positioned alongside the anterior–
posterior commissure line. Matlab (MATLAB and Statistics
Toolbox 2012a) and Statistical Parametric Mapping (SPM 8;
Wellcome Department of Imaging Neuroscience, London) were
used for MRI analysis. The calculation of ASL data was conducted
using the aslm toolbox for SPM8 (ASL Imaging Toolbox) (53). Data
were visually screened for motion (>3 mm in x, z, or z direction or
>3° rotation) and scanner artifacts. Voxelwise mean rCBF for each
subject was calculated from flow-time series, subtracting labeled and
non-labeled images (54). After realignment and co-registration to
the gray matter (GM)-segmented T1 images, normalization was
conducted using the SPM Montreal Neurologic Institute T1
template. Spatial smoothing was done with an 8-mm full-width at
half maximum kernel. Mean rCBF data were finally normalized [z =
(voxel rCBF − global GM rCBF)/SD across individual brain voxels]
and GM corrected using GM segments as inclusive masks.
Statistical Analyses
Behavioral data were analyzed using SPSS (IBM SPSS Statistics for
Windows, released 2016, Version 24.0., IBM Corp., Armonk, NY,
United States).
For behavior and sample characteristics, frequencies were
compared by chi-square tests and continuous or ordinal data with
Kruskal–Wallis H tests. Fisher’s exact tests were used when any cells
from the chi-square tests contained less than five observations.
For MRI analyses, two-sample t-tests were conducted to
compare rCBF between CHR subjects with and without DP/
DR (MRI sample 1) and between subjects with DP/DR disorder
and healthy controls (MRI sample 2). The results of MRI sample
1 are reported family wise error (FWE), whole brain, corrected at
p < 0.05. For MRI sample 2, results are reported following small
volume correction for the region of interest (ROI: frontal,
temporal and/or striatal areas) and with FWE corrected at p <
0.05. This less conservative approach was used for MRI sample 2
because of its small sample size.September 2020 | Volume 11 | Article 535652
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Demographics and Psychopathology
of Sample 1
The three groups (CHR, FEP, and CC) differed regarding their
SOFAS score due to a significantly lower score in FEP compared
to CC (see Table 1). Further, CHR subjects more often qualified
for affective and anxiety disorders and presented more DP/DR
symptoms than FEP and CC. There was a significant difference
in individuals reporting DP/DR symptoms between CHR andFrontiers in Psychiatry | www.frontiersin.org 5CC (50.5 vs. 16.5%; c2(2) = 24.218, p ≤ 0.001, Cramer’s V = 0.359)
as well as between FEP and CC (37.9 vs. 16.5%; c2(2) = 5.960, p =
0.015, Cramer’s V = 0.223), indicating moderately higher scores
in FEP and CHR as compared to CC (see Table 1).Demographics of MRI Sample 1
The CHR subjects with DP/DR symptoms differed regarding age,
education, and ICD-10 DP/DR disorder from those without DP/
DR symptoms (see Table 2).TABLE 1 | Sociodemographic and clinical characteristics of the complete sample 1 (CHR, FEP, CC).
Total CHR FEP CC Statistical valuesa
N = 217 n = 97 n = 29 n = 91
Age in years
mean ± SD 19.2 ± 4.6 18.8 ± 3.9 20.5 ± 6.4 19.2 ± 4.7 H=0.758, p=0.684, df=2, ϵ2 = 0.004
Median 17.8 17.6 18.5 17.8
Range 13–40 13–35 13-40 13-37
SOFAS score
mean ± SD 61.0 ± 12.0 60.1 ± 11.0 55.1 ± 11.3 63.7 ± 12.7 H=10.841, p=0.004, df=2, ϵ2 = 0.050b
Median 61.0 61.0 55.0 65.0
Range 32–89 35–83 35-75 32-89
Gender, male (n, %) 126 58.1 52 53.6 16 55.2 58 63.7 c2(2)=2.093, p=0.351, V=0.098
Current partnership, yes (n, %) 48 22.1 17 17.5 9 31.0 22 24.2 c2(2)=3.384, p=0.184, V=0.131
Nationality, Swiss (n, %) 189 87.1 86 88.7 23 79.3 80 87.9 c2(2)=0.099, p=1.000, V=0.011
Highest education (n, %) c2(4)=3.399, p=0.463, V=0.149
ISCED 1 (6 school years) 5 2.3 1 1.0 0 0.0 4 4.4
ISCED 2 (9–10 school years) 138 63.6 62 63.9 22 75.9 54 59.3
ISCED 3 (12–13 school years) 58 26.7 28 28.9 6 20.7 24 26.4
Currently employed or in training/school (n, %)c 185 85.3 84 86.6 22 75.9 79 86.8 c2(2)=0.301, p=0.920, V=0.026
Current alcohol misuse, present (n, %) 10 4.6 5 5.2 1 3.4 4 4.4 c2(2)=0.197, p=1.000, V=0.012
Current drug misuse, present (n, %) 16 7.4 10 10.3 0 0.0 6 6.6 c2(2)= 2.385, p=0.288, V=0.121
Any current ICD-10 diagnosis (n, %)
Any affective disorder (F30–F39) 74 34.1 44 45.4 8 27.6 22 24.2 c2(2)=9.207, p=0.010, V=0.220
Any anxiety disorder (F40–F41) 37 17.1 25 25.8 3 10.3 9 9.9 c2(2) =7.449, p=0.021, V=0.198
Any eating disorder (F50) 3 1.4 2 2.1 0 0.0 1 1.1 c2(2)=0.536, p=1.000, V=0.056
OCD (F42) 12 5.5 5 5.2 1 3.4 6 6.6 c2(2) =0.373, p=0.908, V=0.042
PTBSD (F43.1) 1 0.5 1 1.0 0 0.0 0 0.0 c2(2)=1.669, p=1.000, V=0.075
DP/DR disorder (F48.1) 18 8.3 12 12.4 0 0.0 6 6.6 c2(2)=4.803, p=0.080, V=0.153
DP/DR symptoms, present (n, %) 75 34.6 49* 50.5 11 37.9 15* 16.5 c2(2)=24.212, p ≤ 0.001, V=0.334
DP symptom, present (n, %) 29 13.4 18 21.2 5 19.2 6 6.8 c2(2)=8.136, p=0.016, V=0.196
DR symptoms, present (n, %) 64 29.5 43* 44.3 10 34.5 11* 12.4 c2(2)=23.048, p ≤ 0.001, V=0.327
Psychotic disorders (F20–F29) (n, %) 29 100.0
Schizophrenia or -like psychotic disorder 16 55.2
Acute psychotic disorder 4 13.8
Delusional schizophrenia 2 6.9
Psychotic disorder unspecified 4 13.8
Major depression with psychotic symptoms 2 6.9
Bipolar disorder with psychotic symptoms 1 3.4
Any CHR criteria
APS (n, %) 68 70.1
BLIPS (n, %) 2 2.1
COPER (n, %) 59 60.8
COGDIS (n, %) 37 38.1SeptembCHR, Clinical High Risk; FEP, First Episode Psychosis; CC, Clinical Controls; SOFAS, Social and Occupational Functioning Assessment Scale of DSM-IV; ISCED, International Standard
Classification of Education; OCD, Obsessive-compulsive Disorder; PTBSD, Post Traumatic Stress Disorder; DP/DR, Depersonalization/Derealization; UHR, Ultra-High Risk; BS, Basic
Symptoms; APS, Attenuated Positive Symptoms according to SIPS, Structured Interview for Psychosis-Risk Syndrome and/or CAARMS, Comprehensive Assessment of At-Risk Mental
States; BLIPS, Brief Limited Intermittent Psychotic Symptoms; COPER, Cognitive-Perceptive Basic Symptoms; COGDIS, Cognitive Disturbances
aEffect sizes reported as Cramer’s V for c2-tests and Fisher’s exact tests; 0.1 equals a small effect, 0.3 a medium effect and 0.5 a large effect.
bFEP vs. CC (z=−3.191, p=0.004, r=0.299, n=114).
cIncludes sheltered employment, temporary employment, and regular full- and part-time employment (incl. schooling, academic studies, occupational training, full-time house work).
*Standardized cell residuum higher or lower than 1.96.
Bold means that the results are significant.er 2020 | Volume 11 | Article 535652
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There were no differences in age (H = 0.232, p = 0.630, ϵ2 =
0.021) nor sex (c2(2) = 1.500, p = 0.545, Cramer’s V = 0.354)
between the group with DP/DR disorder and healthy controls.rCBF in MRI Sample 1
A significantly decreased rCBF was found in the left orbitofrontal
cortex, Brodmann Area 11, (x/y/z = −16/42/−22, t = 5.3, cluster
size = 226, FWE whole brain corrected, p = 0.029) in CHR subjects
compared to those without DP/DR symptoms (Figure 1).rCBF in MRI Sample 2
A significantly increased rCBF was discovered in the left caudate
nucleus (x/y/z = −18/−32/18, t = 7.6, cluster size = 95) and in the
left inferior temporal gyrus (x/y/z = −60/−44/−20, t = 6.7, clusterFrontiers in Psychiatry | www.frontiersin.org 6size = 87) in patients with DP/DR disorder compared to healthy
controls. The increase of rCBF in the left caudate nucleus
survived FWE (p < 0.05) and small volume correction for the
region of interest (Figure 2).DISCUSSION
This study found a high frequency of DP/DR symptoms in CHR
subjects (50.5%) and applied ASL-MRI to investigate DP/DR
symptoms for the first time. Using an identical neuroimaging
approach, the present study investigates resting state neuronal
activity in two different clinical samples, one sample of CHR
subjects with a known high prevalence of DP/DR symptoms and
an independent sample with DP/DR disorder, exclusively. We
found two different brain regions involved with symptoms ofTABLE 2 | Sociodemographic and clinical characteristics of clinical high risk (CHR) subjects for psychosis with and without DP/DR with available MRI scans.
CHR Total CHR with DP/DR CHR without DP/DR Statistical valuesa
N = 44 n = 21 n = 23
Age in years
mean ± SD 19.8 ± 4.4 20.9 ± 3.9 18.8 ± 4.7 H=4.476, p=0.034, df=1, ϵ2 = 0.104
Median 18.4 21.1 17.4
Range 13-35 15–26 13–35
SOFAS score
mean ± SD 63.1 ± 10.4 64.7 ± 9.9 61.7 ± 10.9 H=0.830, p=0.362, df=1, ϵ2 = 0.019
Median 65.0 70.0 65.0
Range 43–82 48–82 43–75
Gender, male (n, %) 24 54.5 11 52.4 13 56.5 c2(1) =0.076, p=0.783, V=0.042
Current partnership, yes (n, %) 9 20.5 4 19.0 5 21.7 c2(1) =0.212, p=0.719, V=0.072
Nationality, Swiss (n, %) 39 88.6 20 95.2 19 82.6 c2(1)=1.738, p=0.348, V=0.199
Highest education (n, %) c2(2)=13.685, p ≤ 0.001, V=0.561
ISCED 1 (6 school years) 1 2.3 0 0.0 1 4.3
ISCED 2 (9–10 school years) 27 61.4 8 38.1 19 82.6
ISCED 3 (12–13 school years) 15 34.1 13* 61.9 2* 8.7
Currently employed or in training/school (n, %)b 39 88.6 20 95.2 19 82.6 c2(1)=1.738, p=0.348, V=0.199
Current alcohol misuse, present (n, %) 3 6.8 2 9.5 1 4.3 c2(1)=0.463, p=0.599, V=0.103
Current drug misuse, present (n, %) 3 6.8 1 4.8 2 8.7 c2(1)=0.267, p=1.000, V=0.078
Any current ICD-10 diagnosis (n, %)
Any affective disorder (F30–F39) 21 47.7 13 61.9 8 34.8 c2(1)=2.968 p=0.085, V=0.269
Any anxiety disorder (F40–F41) 10 22.7 4 19.0 6 26.1 c2(1)=0.222, p=0.728, V=0.072
Any eating disorder (F50) 0 0.0 0 0.0 0 0.0
OCD (F42) 1 2.3 0 0.0 1 4.3 c2(1)=0.934, p=1.000, V=0.146
PTBSD (F43.1) 0 0.0 0 0.0 0 0.0
DP/DR disorder (F48.1) 5 11.4 5 23.8 0 0.0 c2(1)=6.178, p=0.019, V=0.375
DP/DR symptoms, present (n, %) 21 47.7 21 100 0 0.0
DP symptom, present (n, %) 8 18.2 8 38.1 0 0.0
DR symptoms, present (n, %) 19 43.2 19 90.5 0 0.0
Any CHR criteria
APS syndrome (n, %) 34 77.3 16 76.2 18 78.3 c2(1)=0.27, p=1.000, V=0.025
BLIPS syndrome (n, %) 0 0.0 0 0.0 0 0.0
COPER (n, %) 29 65.9 15 71.4 14 60.9 c2(1)=0.545, p=0.460, V=0.111
COGDIS (n, %) 20 45.5 10 47.6 10 43.5 c2(1)=0.076, p=0.783, V=0.042SeptemberMRI scans were not mandatory for subjects in the CHR group. The MRI subsample was made out of the whole CHR subject group (see Table 1) with available MRI scans.
MRI, Magnet Resonance Imaging; CHR, Clinical High Risk; DP/DR, Depersonalization/Derealization; SOFAS, Social and Occupational Functioning Assessment Scale of DSM-IV; ISCED,
International Standard Classification of Education; OCD, Obsessive-compulsive Disorder; PTBSD, Post Traumatic Stress Disorder; UHR, Ultra-High Risk; BS, Basic Symptoms; APS,
Attenuated Positive Symptoms according to SIPS, Structured Interview for Psychosis-Risk Syndrome and/or CAARMS, Comprehensive Assessment of At-Risk Mental States; BLIPS,
Brief Limited Intermittent Psychotic Symptoms; COPER, Cognitive-Perceptive Basic Symptoms; COGDIS, Cognitive Disturbances.
aEffect sizes reported as Cramer’s V for c2-tests and Fisher’s exact tests; 0.1 equals a small effect, 0.3 a medium effect and 0.5 a large effect.
bIncludes sheltered employment, temporary employment, and regular full- and part-time employment (incl. schooling, academic studies, occupational training, full-time house work).
*Standardized cell residuum higher or lower than 1.96.
Bold means that the results are significant.2020 | Volume 11 | Article 535652
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The left orbitofrontal cortex showed a lower rCBF in CHR
subjects with DP/DR symptoms than without, whereas the left
caudate nucleus demonstrated a higher rCBF in patients with
DP/DR disorder than healthy controls.
The two significant brain regions differ with regard to their
structural connections and functions. The orbitofrontal cortex
(Brodmann area 11) is heavily connected to the limbic areas, e.g.
amygdala, hippocampus, and temporal cortex, and the striatum.
It receives visual inputs from the temporal cortex and auditory
inputs and somatosensory inputs from somatosensory cortical
areas and the insula and sends outputs to the temporal cortex,
cingulate cortex, and caudate nucleus. The orbitofrontal cortex
plays a major role in the computation of expected values and
outcome values and their difference and is implicated in positive
prediction error signaling via dopaminergic neurons in the
striatum (55, 56). Other functions of the orbitofrontal cortex
are somatosensory integration e.g. pleasant/painful touch, visual
inputs, e.g. face discrimination, reward representation, and
cognitive enhancement of the value of affective stimuli (55).
Thus, it is important for emotional, perceptional, and cognitive
processing-functions that might be disturbed in DP/DR.
Moreover, orbitofrontal cortex dysfunction has been implicatedFrontiers in Psychiatry | www.frontiersin.org 7in various psychiatric disorders such as borderline personality
disorder, posttraumatic stress disorder, major depression, panic
disorder or manifest psychosis (57) that can also show DP/DR
symptoms (6). Finally, structural and functional findings within
the orbitofrontal cortex have been associated with manifest
psychosis (58, 59), and psychosis risk findings from the
NAPLS study (N = 274 UHR subjects, including 35 converters)
indicated that converters experienced a steeper rate of gray
matter loss in the medial orbitofrontal cortex (60).
The caudate nucleus is connected with the motoric, sensory,
and dorsolateral prefrontal cortex and the lateral orbitofrontal
cortex (61, 62). The caudate nucleus is important for the
inhibition of motoric impulses and basal learning processes (62)
and also for higher cognitive functions including goal-directed
actions. It contributes to behavior through the excitation of
correct action schemas and the selection of appropriate sub-
goals (63) and also to emotions and motivation (64).
Dysfunction of the caudate nucleus supported the role as a
regulator of fronto-striatal circuits (61) and has been
functionally and structurally involved in the pathogenesis of
psychosis (65, 66).
Importantly, the orbitofrontal cortex and the caudate nucleus
are interconnected and interact with each other through aFIGURE 2 | Arterial Spin Labeling Analysis for gray matter regional cerebral blood flow (rCBF), whole brain, T-contrast in DP/DR disorder patients (n = 6) vs. healthy
controls (n = 6), uncorrected at p < 0.001 (x/y/z = −60/−44/−20, t = 6.7). Yellow areas indicate significantly increased CBF in the left caudate nucleus in DP/DR as
compared to controls.FIGURE 1 | Arterial Spin Labeling analysis for gray matter regional cerebral blood flow (rCBF), whole brain, T-contrast in CHR subjects with (n = 21) vs. without (n =
23) DP/DR, uncorrected at p < 0.001 (x/y/z = −16/42/−22, t = 5.3). Red areas indicate significantly decreased CBF in the left orbitofrontal cortex in the CHR group
with DP/DR.September 2020 | Volume 11 | Article 535652
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has become an influential concept in cognitive neuroscience,
signifying a highly interactive information exchange where
incoming information in lower level sensory regions (e.g.
auditory input) is modified by higher level cognitive processes
(e.g. frontal cortex) and vice versa (55, 64, 67, 68). The
orbitofrontal cortex is involved in top-down and the caudate
nucleus in bottom-up processing (69, 70). In predictive coding,
sensory perceptions are combined with prior beliefs, thus
depending on the successful interaction of bottom-up and top
down processes. Prediction errors are defined as the difference
between expectations based on the past and the actual outcome
(71–74). In psychosis, defective prediction errors may lead to
symptoms such as delusions and hallucinations.
Our data suggest that cerebral areas involved in both bottom
up and top down processes can be disturbed and therefore lead to
DP/DR symptoms. Dysfunctions of the orbitofrontal cortex
could change perception “top down” via cognition and faulty
error prediction in CHR subjects, whereas dysfunctions within
the caudate nucleus could change perception “bottom-up” via
sensory information in patients with DP/DR disorder.
In particular, the caudate nucleus and also the orbitofrontal
cortex have previously shown to play a role in DP/DR symptoms
(23, 24, 30, 31). Whole brain MRI analyses of gray matter volume
in patients with DP/DR and healthy controls showed a decrease in
gray matter in the right caudate nucleus that was associated with
DP/DR symptom severity (23). Research investigating white matter
brain connectivity, using network-based statistics, found a trend
supporting the fronto-limbic hypothesis (24). Lower fractional
anisotropy in patients with DP/DR than in healthy controls was
found in the left caudate nucleus, brainstem, and right amygdala,
whereas higher anisotropy was found in the left superior frontal
gyrus and right medial orbitofrontal cortex (24). Importantly, one
study reported a hypoperfusion of the orbitofrontal cortex
(Brodmann area 11) and the left caudate nucleus in a patient
group with DP/DR symptoms compared to healthy controls (31).
The theory of the fronto-limbic system assumes that the frontal
cortex activity is increased (22), but we found a lower rCBF in the
orbitofrontal cortex in subjects with DP/DR symptoms. ASL-MRI
has many advantages (75–77); however, the nature of cells
(excitatory or inhibitory) that contribute to the signal remains
unresolved (78). Therefore, brain regions can increase or decrease
according to themajor cell types (e.g. glutamatergic vs.GABAergic)
that contribute to the signal.
Finally, a PET study reported decrease [11C]raclopride
receptor binding potential in the caudate nucleus and putamen
bilaterally followed by an increase in the endogenous dopamine
availability simultaneously with the emergence of DP/DR
symptoms after intake of psilocybin (30).
Hence, imaging studies examining DP/DR reported findings in
the caudate nucleus and the orbitofrontal cortex but also
mentioned other brain regions, like the temporo-parietal
network or the involvement of the limbic system (21, 28). Our
own data did not clearly demonstrate changes in the temporo-
parietal network or the limbic system. The lack of the involvement
of the temporo-parietal network might be explained by theFrontiers in Psychiatry | www.frontiersin.org 8different symptoms of DP/DR. Feelings of disembodiment and
lack of agency are explained by this system (21, 79), whereas
emotional numbing and perceptual detachment are explained by
the fronto-limbic system. This study did not differentiate the type
of DP/DR to test those systems.
Several disorders show symptoms of DP/DR like posttraumatic
stress disorder, depression, anxiety (1, 7) but also in psychosis (12,
14) and in our study, in CHR subjects. In patients clinically
suspected to develop psychosis, DR as well as both auto- and
somatopsychic DP occurred in roughly 16% of cases, but only DR
was found to be psychosis-predictive (46, 80). An explanation of the
DP/DR symptoms in psychosis is that an impairment of
multisensory integration could lead to incoherent self-experiences,
which then leads to DP/DR. It is hypothesized that the brain’s efforts
to fix that perceptual incoherence could result in hallucinations and
delusions because the focus lies on the DP/DR and no longer on the
real outside world (81); therefore, DP/DR was also considered as a
predelusional state (82). Self-disturbances in CHR subjects, such as
DP/DR, might be potential markers of psychosis (83–85). Self-
disturbances are generally described as anomalies of subjective
experiences such as disruption of the stream of consciousness,
distortion of sense of presence, corporeality or difficulties in self-
demarcation (83). Self-disturbances or self-disorders are
conceptualized as a constellation of interrelated anomalies of
subjective experience gravitating around pervasive distortions of
the “minimal” or “core self” (86). Self-disturbances are usually self-
recognized in CHR subjects due to intact self-monitoring, whereas
in patients transitioning to psychosis those disturbances are no
longer recognized.
Self-disturbances can be measured with the Examination of
Anomalous Self-Experience scale (87) or through some of the
basic symptoms as they are defined as self-experienced
disturbances (15, 86).
DP/DR symptoms were found to be more frequent, had a
longer duration, and were stronger in the early stages of psychosis
than in the chronic stages. Therefore, it was proposed that the
symptoms would predate the onset of psychosis as they were more
often in the early stages than in the chronic ones (8). The
orbitofrontal cortex and caudate nucleus have also been associated
with psychosis (58, 59, 65, 66). Therefore, in future longitudinal
studies, the role of DP/DR symptoms and involved brain regions
(orbitofrontal cortex and caudate nucleus) with regard to a
conversion to psychosis should be investigated. With this, the
potential value of DP/DR symptoms as an additional predictor for
psychosis in CHR subjects could be further evaluated.Strengths and Limitations
One strength of this study is the investigation of two different
samples with the same method. The first sample with CHR
subjects with or without DP/DR symptoms and the second
sample with DP/DR disorder and healthy controls. The ASL-
MRI signal is directly linked to resting-state rCBF and provides a
quantitative and absolute measure of rCBF, reflecting the level of
neuronal activity (34, 35) plus providing the potential to measure
changes in striatal neuronal activity (88–90).September 2020 | Volume 11 | Article 535652
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considered. The small sample size with DP/DR disorder is a major
limitation. Further studies should involve larger samples to
increase the statistical power of the analyses. However, we still
wanted to highlight the findings from this small sample as we
believe the inclusion of this group is of scientific value. The
majority of studies with DP/DR using MRI investigated DP/DR
symptoms in disorders such as major depression, posttraumatic
stress disorder, drug abuse, or borderline personality disorder,
whereas this study investigated pure DP/DR disorder without
comorbidities. Pure DP/DR disorder patients without
concomitant additional diagnoses are difficult to find and hard
to motivate for study participation. With regard to sample size,
several published studies are comparable to our study [e.g. (27,
91)]. Another limitation is the classification of DP/DR. In sample
1, DP/DR was narrowly assessed in a clinical interview through the
SPI-CY/SPI-A and transformed into a binary variable. In the SPI-
A the autopsychic DP was not collected, whereas in the SPI-CY it
was. That could lead to a small bias of CHR with and without DP/
DR symptoms. In sample 2, DP/DR was more broadly assessed,
and participants were grouped into DP/DR or healthy controls.
Because DP/DR is reported to lie on a continuum, analyses would
ideally involve DP/DR on an ordinal scale.
There was no differentiation in symptoms of DP/DR in this
study. Despite that they are subsumed as DP/DR, future studies
should differentiate the symptoms of DP/DR in different subgroups
as this could give more comprehension in the neurobiological
correlations and consider the comorbidities and developmental
aspects such as age. A further limitation is the direct comparison
of the two samples in this study as they were not assessed with the
exact same clinical instruments. Future studies should use the same
instruments to detect psychiatric disorders and CHR symptoms as
well as DP/DR. With the CDS DP/DR could be assessed on a scale
and differentiated, and other disorders or CHR symptoms could be
used as covariates.Conclusion
To summarize, DP/DR symptoms are frequent in CHR subjects.
Investigating two separate DP/DR populations with an identical
neuroimaging technique, we found decreased neuronal activity in
the orbitofrontal cortex but increased activity in the caudate nucleus.
As the orbitofrontal cortex is involved with psychiatric
disorders that are associated with DP/DR symptoms (1, 7, 57),
we conclude that the area is important for the emergence of DP/
DR. According to its function in somatosensory integration, it is
reasonable that DP/DR can be seen as a failure in somatosensory
integration, which could turn into numbing of emotions, altered
body perception, feeling unreal, distorted sense of time, or
perceiving an unreal environment.
The caudate nucleus as part of the striatum is connected to
prefrontal areas (36) and is important for cognitive functions,
emotions, and motivation and could play a role in the control
function from fronto-limbic system and therefore produce DP/
DR symptoms.Frontiers in Psychiatry | www.frontiersin.org 9Our results indicate that there seem to be divergent
mechanisms that finally lead to the same/similar symptoms.
This suggests that top-down (orbitofrontal cortex) and bottom-
up (caudate nucleus) mechanisms might contribute to a different
extent to the emergence of DP/DR, depending on the
manifestation/phenomenology of the symptoms.DATA AVAILABILITY STATEMENT
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